Category: pharma & healthcare

For the past two and half years, Covid-19 introduced a significant risk to travel. Here we discuss how to mitigate this risk.

SARS-CoV-2 makes use of a variety of accessory proteins to evade and suppress our immune response. New research on the accessory protein ORF7a suggests it may help the virus gain easier entry into our cells.

Thanks to vaccines, the United States has been polio-free since 1979. However, there are other lesser known viruses that can cause similar life-threatening neurological conditions. Acute Flaccid Myelitis is one of these conditions, and cases are on the…

Two recent preprint studies demonstrate evidence of potential Paxlovid resistance. These findings present both challenges and opportunities for the future of the pandemic.

Prion diseases are rare, deadly neurodegenerative brain diseases that result from misfolding protein. Recent study encourages the development of antibodies to PrPC to prevent its conversion to PrPSc. If successful, their unique approach illuminates tre…

A new study found that less than 10 percent of children who contracted Covid-19 in 2020 or early 2021 developed neutralizing antibody titers against the Omicron variant of SARS-CoV-2.

With poxviruses now back on the radar, we must consider the outstanding threat of possible human pathogens in much greater detail. It is critically important to understand not only how poxviruses jump from one species to another but also how they evolv…

At present there is a serious outbreak in Iraq of Crimean-Congo Hemorrhagic Fever, a rare but deadly tick-borne disease.

Both the FTC and Congress want to rein in pharmacy benefit managers (PBMs), as they focus on alleged anti-competitive practices which hinder a properly functioning prescription drug market. Maybe this time an inquiry and legislative action will happen,…

While a large Build Back Better bill was scuttled last winter, a substantially slimmed down version may still pass. And, this piece of legislation could contain prescription drug pricing stipulations designed to decrease government spending on pharmace…